this is hero image

Getting Your Patients Started on Eversense 365

We’ve laid out the simple steps from start to finish to help you understand what you and your patients will experience when getting started on Eversense 365 - and we’ll be with you every step of the way.

Three easy steps:

Prescribe Eversense 365 for your patient

Refer patient to Ascensia Diabetes Care by Parachute Health or fax Patient Information Form, Certificate of Medical Necessity, Chart Notes and Insurance Info.
The Eversense Inserter Network will manage the insertion process

Skilled medical professionals who will manage insertion and removal procedures, billing, and scheduling.
Continue your patient care and monitor their progress with DMS Pro

You and your patient will then have full-time access to reliable data that is essential for providing optimal diabetes care.
Connect with an Eversense Expert
An Eversense Expert will reach out to the patient.  After their eligibility is confirmed, they’ll assist in locating an Eversense Inserter nearby, and determine the cost based on their insurance. Use our Find an Inserter tool to find your closest Eversense Inserter.
Order Eversense 365 CGM
We will submit the claim and work directly with your office and a distribution partner to order the Eversense 365 CGM sensor and transmitter.
Product Shipment
Once their Eversense 365 CGM system has been ordered, it will be delivered to the Eversense Inserter’s office. When it ships, we will contact your office and the patient so the patient can schedule their sensor insertion appointment.
The Sensor Insertion Procedure
During a brief office visit, the Eversense Inserter will make a small incision in the arm, insert the sensor and introduce the patient to the smart transmitter and app. The patient leaves the office with materials to ensure their app is set up, and the transmitter is paired to the sensor for one year of accurate continuous glucose monitoring.
Managing Patient Care
After the sensor is inserted and your patient begins using their Eversense 365, you will have access to real-time dependable glucose data through Eversense DMS Pro that can help shape better and more effective treatment plans.

Ready to Become a Provider?

Learn more about what steps you can take to prescribe Eversense 365 or how to become an Eversense Inserter.

CONTACT US
this is 50 | 50 image

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

PP-SENS-E3-GBL-0063